about
N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory propertiesThe endocannabinoid system as an emerging target of pharmacotherapyAnandamide and vanilloid TRPV1 receptorsCharacterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A reviewCannabinoid receptor activation in the juvenile rat brain results in rapid biomechanical alterations: Neurovascular mechanism as a putative confounding factor.Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation.Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational studyEffect of intrapulmonary tetrahydrocannabinol administration in humans.Pharmacodynamic and pharmacokinetic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteers.The complexities of the cardiovascular actions of cannabinoidsHeterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.The endocannabinoid system: physiology and pharmacology.Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusionsBlood pressure regulation by endocannabinoids and their receptorsAngiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningCardiovascular pharmacology of cannabinoids.Endocannabinoids in cerebrovascular regulation.Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitationsMechanisms of endothelial dysfunction in obesity-associated hypertension.Endocannabinoids and cardiac contractile function: pathophysiological implications.The therapeutic potential of novel cannabinoid receptorsThe emerging role of the endocannabinoid system in cardiovascular disease.The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure.The endocannabinoid system as a target for the treatment of neuronal damage.Endothelial atypical cannabinoid receptor: do we have enough evidence?Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repressionChemical determinants involved in anandamide-induced inhibition of T-type calcium channels.Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids.Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.Role of endogenous cannabinoids in ischemia/reperfusion injury following testicular torsion in rats.Cytochrome P450 pathway contributes to methanandamide-induced vasorelaxation in rat aorta.Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels.Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?Binding of anandamide to bovine serum albumin.
P2860
Q24541462-ED659B06-546C-4DDD-A659-83584AE5CC38Q24648473-B19BAA85-3C4F-48E6-B197-EA33AE4F9230Q24672354-E1B5EC74-8F60-492B-BFC7-E7B477DB2505Q28242911-2FBD7B1F-D61D-401B-B909-8D55609958F8Q28257062-E763FEB5-DF9C-4512-B08E-CE8C6AA67D40Q30357699-1135FC32-E22F-486D-B267-15BEF6B7D336Q34214049-FE5C3252-B663-44F9-9FA3-0F3AE2B14D1DQ34545007-EC07D160-208C-4C6C-91DE-032118037E59Q34687393-353AABBC-1F0A-45DB-B840-031072F0112BQ34783254-605E64E5-737B-4548-A08A-894A7553A7F5Q34797473-15E6E918-566E-4A75-A22E-CAC7EB206A69Q35047093-B3039E53-74C2-4DD8-970D-8BFF872462AAQ35047182-4ADA67E5-9F9F-4082-8D8A-5A65050DE203Q35100641-F27F8BCE-3E50-45A3-8B83-A8EB40E5ECF9Q35684044-122A7600-790C-4C56-90B3-CBACC5629AEDQ35954057-1EEE0BCA-7756-4C34-B917-739D8D1B8B98Q36052772-A3C05FD3-4FC3-4377-A077-A26AB617F8F7Q36135785-2E32CD77-C33C-4FFD-8C28-8DC98446C144Q36225837-B9CFFE91-4021-4CA4-A233-26776182BF8BQ36416372-C9CA9311-82CA-4542-9524-5ADE53D43DD9Q36431860-FD5DF8A2-1CF1-4EEC-9E68-E2DF8F97FB92Q36895795-A202AEB6-518F-484A-B24A-2101C296E792Q36940347-50BF4990-0AD9-484D-A71F-27F91D7340C9Q37371166-9F200265-3960-4FD9-9A0C-CD3FC6ADFF77Q37401757-5454750C-0D14-40B4-8B49-D54976F15F1FQ37402927-F49D9B9F-9619-4C70-A75B-E3E5CC823401Q37439386-12C3AB5B-99AC-4CCF-8A28-679C72706E40Q37663368-09A5DBE5-4574-403F-9A75-F8C98AEFF897Q37709370-5020D59D-8349-460A-98DD-D5DF76B7F602Q38235155-D4EB0405-3FF2-4F1C-B957-5BC5868F9A38Q39987047-0823933A-E655-4BAA-BC01-37A42B6555DBQ40205455-8F761B30-6C0D-4191-AFC4-64D9FEC2DD83Q40384021-28738C84-4576-48A0-AC0C-9B3053D0B3E4Q42200119-C647A669-7FF2-4E8F-8B72-4750DF97FD4BQ42435550-B7DC86C6-D0A0-48C8-9C60-D9B671731738Q42918598-1840CF91-55A4-4E0D-B8C8-B2A1F2C8F002Q42940476-09D4609C-5528-4B2E-B33F-92FCD6CF63D0Q43038421-BBE466CA-9474-4D84-B259-D930993B5E85Q43263467-20A9F3F6-22E6-498F-A5A0-F35D771C50FBQ44499481-71D36270-D228-4184-A8C4-A3069581F92E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cardiovascular effects of cannabinoids.
@ast
Cardiovascular effects of cannabinoids.
@en
Cardiovascular effects of cannabinoids.
@nl
type
label
Cardiovascular effects of cannabinoids.
@ast
Cardiovascular effects of cannabinoids.
@en
Cardiovascular effects of cannabinoids.
@nl
prefLabel
Cardiovascular effects of cannabinoids.
@ast
Cardiovascular effects of cannabinoids.
@en
Cardiovascular effects of cannabinoids.
@nl
P2093
P1476
Cardiovascular effects of cannabinoids.
@en
P2093
David A Kendall
David Harris
Michael D Randall
Vera Ralevic
P304
P356
10.1016/S0163-7258(02)00258-9
P577
2002-08-01T00:00:00Z